Interest of a loading dose of milnacipran in endogenous depressive inpatients: Comparison with the standard regimen and with fluvoxamine
- 31 May 1991
- journal article
- clinical trial
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 1 (2) , 113-121
- https://doi.org/10.1016/0924-977x(91)90712-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Intérêt thérapeutique du milnacipran et de la clomipramine au cours d’un traitement de 3 mois: résultats d’un essai comparatifPsychiatry and Psychobiology, 1990
- Milnacipran et trouble obsessionnel-compulsif: étude d'un casPsychiatry and Psychobiology, 1990
- Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatientsHuman Psychopharmacology: Clinical and Experimental, 1989
- Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drugNeuropharmacology, 1985
- A double‐blind placebo‐controlled study of fluvoxamine and imipramine in out‐patients with primary depression.British Journal of Clinical Pharmacology, 1983
- Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor BindingScience, 1980
- Symptomatic volunteers in multicenter drug trialsProgress in Neuro-Psychopharmacology, 1979
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- Development of β-adrenergic receptor subsensitivity by antidepressantsNature, 1977
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960